Yael Mosse
Overview
Explore the profile of Yael Mosse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu C, Huang L, Zhang Z, Ju Z, Song X, Kolb E, et al.
Sci Rep
. 2024 Aug;
14(1):19891.
PMID: 39191826
Osteosarcoma is the most common primary bone malignancy in children and young adults, and it has few treatment options. As a result, there has been little improvement in survival outcomes...
2.
Schoeman S, Bagatell R, Cahill A, Maris J, Mattei P, Mosse Y, et al.
Pediatr Blood Cancer
. 2024 Jan;
71(4):e30887.
PMID: 38291721
Purpose: To determine whether percutaneous core needle biopsy (PCNB) is adequate for the diagnosis and full molecular characterization of newly diagnosed neuroblastoma. Materials And Methods: Patients with newly diagnosed neuroblastoma...
3.
Weiss B, Yanik G, Naranjo A, Zhang F, Fitzgerald W, Shulkin B, et al.
Pediatr Blood Cancer
. 2021 May;
68(10):e29117.
PMID: 34028986
Introduction: I-meta-iodobenzylguanidine ( I-MIBG) is effective in relapsed neuroblastoma. The Children's Oncology Group (COG) conducted a pilot study (NCT01175356) to assess tolerability and feasibility of induction chemotherapy followed by I...
4.
Surrey L, MacFarland S, Chang F, Cao K, Rathi K, Akgumus G, et al.
Genome Med
. 2019 May;
11(1):32.
PMID: 31133068
Background: Somatic genetic testing is rapidly becoming the standard of care in many adult and pediatric cancers. Previously, the standard approach was single-gene or focused multigene testing, but many centers...
5.
Devoto M, Specchia C, Laudenslager M, Longo L, Hakonarson H, Maris J, et al.
Hum Hered
. 2011 Jul;
71(2):135-9.
PMID: 21734404
Background: Neuroblastoma (NB) is an important childhood cancer with a strong genetic component related to disease susceptibility. Approximately 1% of NB cases have a positive family history. Following a genome-wide...
6.
Lipsitz E, Moorthy G, Mosse Y, Fox E, Adamson P
J Chromatogr B Analyt Technol Biomed Life Sci
. 2010 Aug;
878(25):2369-73.
PMID: 20685183
We describe a selective and a highly sensitive high-performance liquid chromatography-electron spray ionization-collision induced dissociation-tandem mass spectrometry (HPLC-ESI-CID-MS/MS) assay for the Aurora A kinase inhibitor MLN8237 in human plasma. The...
7.
Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, et al.
Cancer Res
. 2006 Jun;
66(12):6050-62.
PMID: 16778177
Neuroblastoma is remarkable for its clinical heterogeneity and is characterized by genomic alterations that are strongly correlated with tumor behavior. The specific genes that influence neuroblastoma biology and are targeted...
8.
Margolin A, Greshock J, Naylor T, Mosse Y, Maris J, Bignell G, et al.
Bioinformatics
. 2005 May;
21(15):3308-11.
PMID: 15905276
Summary: This synopsis provides an overview of array-based comparative genomic hybridization data display, abstraction and analysis using CGHAnalyzer, a software suite, designed specifically for this purpose. CGHAnalyzer can be used...
9.
Morowitz M, Shusterman S, Mosse Y, Hii G, Winter C, Khazi D, et al.
Mod Pathol
. 2003 Dec;
16(12):1248-56.
PMID: 14681326
Regional genomic alterations resulting from single-copy allelic loss or gain have been well characterized in many human cancers and are often of prognostic relevance. Unbalanced gain of 17q material is...
10.
Mosse Y, Greshock J, King A, Khazi D, Weber B, Maris J
Lancet Oncol
. 2003 Dec;
4(12):769-71.
PMID: 14662434
No abstract available.